0001144204-17-039572.txt : 20171101 0001144204-17-039572.hdr.sgml : 20171101 20170801160539 ACCESSION NUMBER: 0001144204-17-039572 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REPROS THERAPEUTICS INC. CENTRAL INDEX KEY: 0000897075 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 760233274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2408 TIMBERLOCH PL STREET 2: SUITE B-7 CITY: WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 2817193400 MAIL ADDRESS: STREET 1: 2408 TIMBERLOCH PLACE B-7 CITY: THE WOODLANDS STATE: TX ZIP: 77380 FORMER COMPANY: FORMER CONFORMED NAME: REPROS THERAPEUTICS INC DATE OF NAME CHANGE: 20060503 FORMER COMPANY: FORMER CONFORMED NAME: ZONAGEN INC DATE OF NAME CHANGE: 19930208 CORRESP 1 filename1.htm

REPROS THERAPEUTICS INC.

2408 Timberloch Place, Suite B-7

The Woodlands, Texas 77380

August 1, 2017

VIA EDGAR TRANSMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:

Jeffrey Gabor, Division of Corporation Finance, Office of Healthcare & Insurance

Re:

Repros Therapeutics Inc.

Registration Statement on Form S-3

Filed July 24, 2017

File No. 333-219428

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Repros Therapeutics Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-219428), so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on August 4, 2017, or as soon as practicable thereafter.

	REPROS THERAPEUTICS INC.

	By:	/s/ Kathi Anderson
	Name:	Kathi Anderson
	Title:	Chief Financial Officer